RMHP_A_243048 989..997

Chang Yu 1 Lihua Chen 1 Guanyu Ruan 1,2 Jian An 1 Pengming Sun 1,2 1Laboratory of Gynecologic Oncology, Fujian Provincial Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People’s Republic of China; 2Key Laboratory of Fujian Maternal and Pediatric Major Disease Research, Fujian Provincial Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People’s Republic of China Purpose: To evaluate the level of human papilloma virus (HPV)-related knowledge and vaccination willingness of people in Fujian Province, and to explore the factors influencing doctors’ recommendation of HPV vaccine. Methods: We conducted two cross-sectional surveys in Fujian Province. The study cohort included 248 medical staff and medical students and 1001 community members. Descriptive statistics were used to identify the general demographics of the participants, along with their knowledge and attitudes regarding HPV and vaccination. Analyses were conducted to identify factors associated with willingness to vaccinate and willingness to recommend vaccination. Results: The level of HPV knowledge in Fujian province was found to be low, but more than 80% of participants would like to accept HPV vaccine. Medical staff had a higher willingness to recommend HPV vaccine than students (OR= 4.696, CI: 2.698-8.175), which may be related to work experience and acceptance of vaccine price but not to knowledge level. Conclusion: Knowledge of HPV in our community population appears to be lower than that in other regions in China. We suggest that a lack of knowledge may not be the main factor affecting the willingness to vaccinate, but we still needed to raise the level of knowledge about HPV to prevent misunderstandings. When the level of knowledge is high, education and per capita household income are not important factors influencing the willingness to vaccinate; only acceptance of vaccine prices significantly affects the willingness to vaccinate. Inclusion of the HPV vaccine in the national immunization program could help to alleviate public concerns regarding the vaccine to change present situation.

[1]  Zulida Rejali,et al.  Sociodemographic determinants of knowledge and attitude in the primary prevention of cervical cancer among University Tunku Abdul Rahman (UTAR) students in Malaysia: preliminary study of HPV vaccination , 2019, BMC Public Health.

[2]  L. Engstrand,et al.  Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine , 2019, Front. Cell. Infect. Microbiol..

[3]  A. Dey,et al.  Immunisation coverage annual report, 2015 , 2019, Communicable diseases intelligence.

[4]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[5]  T. H. Nguyen,et al.  Knowledge, attitude, and practice on and willingness to pay for human papillomavirus vaccine: a cross-sectional study in Hanoi, Vietnam , 2018, Patient preference and adherence.

[6]  J. Douwes,et al.  Knowledge, attitudes and awareness of the human papillomavirus among health professionals in New Zealand , 2018, bioRxiv.

[7]  Ayinuer Maimaiti,et al.  Knowledge of cervical cancer and Pap smear among Uyghur women from Xinjiang, China , 2018, BMC Women's Health.

[8]  Y. Fang,et al.  [Analysis of mothers' acceptance of HPV vaccination of adolescent girls in Xiamen]. , 2018, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[9]  Linda Huibers,et al.  Paper- or Web-Based Questionnaire Invitations as a Method for Data Collection: Cross-Sectional Comparative Study of Differences in Response Rate, Completeness of Data, and Financial Cost , 2018, Journal of medical Internet research.

[10]  Kenneth K C Man,et al.  Mothers' Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters: A Discrete Choice Experiment in Hong Kong. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[11]  Yuanyue Li,et al.  Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[12]  Ruoran Li,et al.  Human papillomavirus vaccine approval in China: a major step forward but challenges ahead. , 2016, The Lancet. Infectious diseases.

[13]  S. M. Sherman,et al.  Knowledge, attitudes and awareness of the human papillomavirus amongst primary care practice nurses: an evaluation of current training in England , 2016, Journal of public health.

[14]  D. Jamison,et al.  extended cost-effectiveness analysis of publicly financed HPV accination to prevent cervical cancer in China , 2015 .

[15]  A. Giuliano,et al.  Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. , 2011, Vaccine.

[16]  Ji-Hong Liu,et al.  Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18 , 2009, Cancer Causes & Control.

[17]  A. Shefer,et al.  Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. , 2009, Preventive medicine.

[18]  Y. Qiao,et al.  Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. , 2009, Vaccine.

[19]  Risk Management and Healthcare Policy Dovepress , 2022 .